The effect of bile duct stenting in reducing the number and size of gallstones

The effect of biliary stent placement in reducing the number and size of gallstones in patients with difficult gallstones.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191104045328N25

Enrollment

Registered

2024-08-26

Start date

2024-08-24

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Difficult gallstones. Gallstone ileus

Interventions

Intervention group: Performing a plastic stent by primary ERCP in all patients with difficult gallstones larger than 1 cm and draining it by secondary ERCP after two months..

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with difficult gallstones (size of stones more than 1 cm) Age above 18 years Consent to participate in the study

Exclusion criteria

Exclusion criteria: Having a history of chronic and severe liver, kidney and heart disease

Design outcomes

Primary

Measure	Time frame
The number of stones. Timepoint: At the beginning of stent placement and after two months of stent placement. Method of measurement: Endoscopic Retrograde Cholangiopancreatography.;The sum of the largest diameters of the stones. Timepoint: At the beginning of stent placement and after two months of stent placement. Method of measurement: Endoscopic Retrograde Cholangiopancreatography.;Side effects (infection, cholangitis, pancreatitis, perforation). Timepoint: During treatment and after stent removal. Method of measurement: Patient history and physical examination.	—

Measure

Time frame

The number of stones. Timepoint: At the beginning of stent placement and after two months of stent placement. Method of measurement: Endoscopic Retrograde Cholangiopancreatography.;The sum of the largest diameters of the stones. Timepoint: At the beginning of stent placement and after two months of stent placement. Method of measurement: Endoscopic Retrograde Cholangiopancreatography.;Side effects (infection, cholangitis, pancreatitis, perforation). Timepoint: During treatment and after stent removal. Method of measurement: Patient history and physical examination.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Hamidreza Norouzi

Arak University of Medical Sciences

hrn65@yahoo.com+98 86 3417 3601

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026